Company Filing History:
Years Active: 2021-2025
Title: Fei Wen: Innovator in Nano-Satellite Complexes and Immunotherapy
Introduction
Fei Wen is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the fields of nano-satellite complexes and immunotherapy. With a total of 3 patents, his work is paving the way for advancements in cancer treatment and immune system activation.
Latest Patents
Fei Wen's latest patents include innovative technologies in nano-satellite complexes. One of his notable inventions provides methods, compositions, systems, and kits that comprise nano-satellite complexes. These complexes feature a core nanoparticle complex with a biocompatible coating surrounding a nanoparticle core. Additionally, they include 3-25 satellite particles attached to or absorbed by the biocompatible coating, along with a plurality of antigenic peptides conjugated to or absorbed by the satellite particles. In some embodiments, the administration of these nano-satellite complexes to subjects with cancer can achieve long-term remission, especially when combined with immune checkpoint inhibitors like αPD1. Another significant patent focuses on immunotherapy, detailing compositions, methods, and kits for activating T cells using a peptide-major histocompatibility complex (pMHC) assembled on a protein scaffold. This technology aims to present T cell activating ligands in a patterned manner to enhance immune responses.
Career Highlights
Fei Wen is affiliated with the University of Michigan, where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential impact on cancer therapies and immunological advancements.
Collaborations
Fei Wen collaborates with notable colleagues, including Brett Dallas Hill and Syed Monem Rizvi. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Fei Wen is a distinguished inventor whose work in nano-satellite complexes and immunotherapy is making significant strides in medical science. His innovative patents reflect a commitment to improving cancer treatment and enhancing immune responses.